ClinicalTrials.gg
Sign In
RecruitingNCT06205186Updated Sep 15, 2026

Four Pillars of Defense: A Whole Health Approach to the Military

An interventional study of Army Health in Health Behavior, sponsored by Pennington Biomedical Research Center. Recruiting at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Pennington Biomedical Research Center · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Study summary

The overall objectives of this study are to better define the construct of psychological resilience in the military, to identify potential modifiable risk factors and trainable skills of psychological resilience in Soldiers, and provide a scalable, integrated physical and mental optimization training app to be integrated into relevant systems. The proposed work would be a first step in identifying predictive risk factors that can be modified to increase the future resilience of Soldiers. With this crucial information, the investigators aim to gather data that will inform the development of a resilience-focused intervention (e.g., a skills training program) and test the feasibility of that intervention.

02

Conditions studied

  • Health Behavior

Browse trials for

Keywords

  • Soldier
  • Resilience
03

In context

Health Behavior

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

This study's planned enrollment of 400 is above the median of 150 across 824 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Pennington Biomedical Research Center is the lead sponsor of 284 studies on the registry; 31 are open to participants now.

Browse Pennington Biomedical Research Center studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 21+ and either a Soldier in the NG or NG family member

Exclusion criteria

Exclusion Criteria:

  • Under age 21 and not an NG Soldier or family member
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Other
    Program Users

    Behavioral: Army Health

Interventions

  • BehavioralArmy Health

    A whole health mobile application for Soldiers

06

What researchers measure

Primary outcomes

  1. Resilience

    Connor Davidson Resilience Scale (CDRISC)

    Time frame: 1 month

  2. Resilience

    Brief Resilience Scale (BRS)

    Time frame: 1 month

  3. Emotion Regulation

    Difficulty in Emotion Regulation Scale (DERS)

    Time frame: 1 month

  4. Experiential Avoidance

    Multidimensional Experiential Avoidance Questionnaire (MEAQ-30)

    Time frame: 1 month

  5. Intolerance of Uncertainty

    Intolerance of Uncertainty Scale (IUS-12)

    Time frame: 1 month

  6. Coping

    Brief COPE

    Time frame: 1 month

  7. Positive and Negative Social Exchanges

    Positive and Negative Social Exchanges (PANSE)

    Time frame: 1 month

  8. Post Traumatic Stress Disorder (PTSD)

    PTSD Checklist (PCL-5)

    Time frame: 1 month

  9. Sleep

    Pittsburgh Sleep Quality Index (PSQI)

    Time frame: 1 month

  10. Social Support

    Social Support Survey (SSS)

    Time frame: 1 month

  11. Responses to Stressful Experiences

    Responses to Stressful Experiences Scale (RSES)

    Time frame: 1 month

  12. Unit Cohesion

    Questionnaire

    Time frame: 1 month

  13. Depression

    Patient Health Questionnaire (PHQ-8)

    Time frame: 2 weeks

  14. Anxiety

    Generalized Anxiety Disorder (GAD7)

    Time frame: 2 weeks

  15. Stress

    Perceived Stress Scale (PSS)

    Time frame: 1 month

  16. Drug Abuse

    Drug Abuse Screening Test (DAST-10)

    Time frame: 12 months

Secondary outcomes

  1. Topics Ranking

    Questionnaire

    Time frame: 1 month

  2. Technology Use

    Questionnaire

    Time frame: 1 month

  3. Program Satisfaction

    Questionnaire

    Time frame: 6 Months

07

Study locations

1 of 1 sites recruiting
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Jan 2027, 34 months after the start.

Of 567 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 34 months is above that.

Counting every sponsor, half of 585 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2023
First posted
Jan 12, 2024
StartActual
Mar 8, 2024
Primary completionEst.
Jan 15, 2027
CompletionEst.
Jan 15, 2027
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06205186
Lead sponsor
Pennington Biomedical Research Center
Responsible party
Tiffany Stewart (Professor, Pennington Biomedical Research Center) — Principal investigator
First posted
Jan 12, 2024
Start date
Mar 8, 2024
Primary completion
Jan 15, 2027 (estimated)
Completion
Jan 15, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

Nicole Wesley
Contact
nicole.wesley@pbrc.edu
2257632721

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Health Behavior →

Other studies from this sponsor

Pennington Biomedical Research Center →

Start the discussion